What do you do when the cat is let out of the bag, and has been for several months? That is the quandary facing the American College of Cardiology (ACC) with one of its late-breaking clinical trials.

Wyoming hospitals that achieve accreditation by nationally recognized accrediting bodies for care of STEMI and stroke will now receive public recognition from the Wyoming Health Department. In what an American Heart Association (AHA) official called “a great first step,” Wyoming Gov. Matt Mead signed a bill requiring the public recognition on Feb. 28.

Predicting atrial fibrillation (AF) risk in otherwise healthy women with no known cardiovascular disease may require only easily obtainable information that is readily available to physicians and other healthcare practitioners, according to a study published online Feb. 26 in the European Heart Journal.

Medtronic has received CE Mark for its Engager transcatheter aortic valve implantation (TAVI) system with transapical delivery catheter to treat patients with severe aortic stenosis who are at high or extreme risk for surgical aortic valve replacement.

Massachusetts General Hospital launched the Mass General Institute for Heart, Vascular and Stroke Care, which is seeking to integrate cardiovascular and cerebrovascular care. Michael R. Jaff, DO, chair of the Institute speaks to the benefits and challenges of approaching patients in a new way.

The European Medicines Agency (EMA) once again gave a cold shoulder to Qsiva as a treatment for severely obese or obese patients, citing concerns about long-term cardiovascular effects.

Researchers evaluate how patient characteristics, procedural approach and devices impact transcatheter aortic valve replacement (TAVR) outcomes.

In November 2009, Cardiovascular Business asked if the much-anticipated FREEDOM trial would “set us free” by better informing decisions to treat high-risk diabetics with multivessel disease using either PCI or CABG.